Endpoints News ٢٤ فبراير ٢٠٢٦ Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market
Endpoints News ٢٣ فبراير ٢٠٢٦ Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial
Endpoints News ٩ فبراير ٢٠٢٦ Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages
Endpoints News ٤ فبراير ٢٠٢٦ Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
FierceBiotech ٢٨ يناير ٢٠٢٦ With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
FierceBiotech ٢١ يناير ٢٠٢٦ Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat
Endpoints News ١٦ يناير ٢٠٢٦ Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisai
Endpoints News ١٥ يناير ٢٠٢٦ A compounding pharmacy hits back at Eli Lilly, Novo Nordisk with antitrust lawsuit
Endpoints News ١٥ يناير ٢٠٢٦ FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory
FierceBiotech ١٥ يناير ٢٠٢٦ Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
Endpoints News ١٥ يناير ٢٠٢٦ Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035
Endpoints News ١٢ يناير ٢٠٢٦ #JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
Endpoints News ٥ يناير ٢٠٢٦ Novo Nordisk launches Wegovy pill at $25 per month for insured patients, $149 cash
Endpoints News ١٧ ديسمبر ٢٠٢٥ Novo Nordisk hit with FDA warning letter over acquired Catalent factory